Reduction in the severity of graft-versus-host disease and increased survival in allogenic mice by treatment with monoclonal antibodies to cell adhesion antigens LFA-1 alpha and MALA-2 - PubMed (original) (raw)
Reduction in the severity of graft-versus-host disease and increased survival in allogenic mice by treatment with monoclonal antibodies to cell adhesion antigens LFA-1 alpha and MALA-2
R Harning et al. Transplantation. 1991 Nov.
Abstract
Bone marrow transplantation is a therapeutic treatment for many life-threatening hematologic disorders, especially leukemia and certain immune deficiency diseases. However, acute graft-versus-host disease is often associated with bone marrow transplantation. In mice, allogeneic GVHD appears to be mediated by both host natural killer cells and donor T cells. In vitro and in vivo experiments demonstrate that treatment with either YN1/1.7 or M17/4.2 mabs is immunomodulatory and inhibits both the mixed lymphocyte reaction and natural killer cell activity. In addition, utilizing an allogeneic model of acute, lethal GVHD with C57B1/6 mice as donors and sublethally irradiated BDF1 mice as recipients, treatment of host mice with anti-LFA-1 alpha (M17/4.2) or anti-MALA-2 (YN1/1.7) mabs at a dose of 10 mg/kg/day for 10 days significantly reduced GVHD and enhanced survival. Mabs to lymphocyte adhesion molecules such as LFA-1 alpha and MALA-2 may provide a useful therapy for the treatment of GVHD.
Similar articles
- Amelioration of acute graft-versus-host disease and re-establishment of tolerance by short-term treatment with an anti-TCR antibody.
Maeda T, Eto M, Lin T, Nishimura Y, Kong YY, Nomoto K, Nomoto K. Maeda T, et al. J Immunol. 1994 Nov 1;153(9):4311-20. J Immunol. 1994. PMID: 7930630 - Different roles for LFA-1 and VLA-4 integrins in T-B-cell interactions in vivo.
López-Hoyos M, Revilladagger C, Conde C, Del Campo EG, González A, Merino J. López-Hoyos M, et al. Immunology. 1999 Jul;97(3):438-46. doi: 10.1046/j.1365-2567.1999.00794.x. Immunology. 1999. PMID: 10447765 Free PMC article. - Awareness of donor alloantigens in antiadhesion therapy induces antigen-specific unresponsiveness to islet allografts.
Nishihara M, Gotoh M, Ohzato H, Ohta Y, Luo Z, Dono K, Umeshita K, Sakon M, Monden M, Yagita H, Okumura K, Miyasaka M. Nishihara M, et al. Transplantation. 1997 Oct 15;64(7):965-70. doi: 10.1097/00007890-199710150-00005. Transplantation. 1997. PMID: 9381542 - Suppression of graft-versus-host disease and amplification of graft-versus-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation.
Asai O, Longo DL, Tian ZG, Hornung RL, Taub DD, Ruscetti FW, Murphy WJ. Asai O, et al. J Clin Invest. 1998 May 1;101(9):1835-42. doi: 10.1172/JCI1268. J Clin Invest. 1998. PMID: 9576746 Free PMC article. - Specific immunosuppression of corneal allograft rejection by combination of anti-VLA-4 and anti-LFA-1 monoclonal antibodies in mice.
Hori J, Isobe M, Yamagami S, Mizuochi T, Tsuru T. Hori J, et al. Exp Eye Res. 1997 Jul;65(1):89-98. doi: 10.1006/exer.1997.0316. Exp Eye Res. 1997. PMID: 9237869
Cited by
- The effect of ADAMTS13 on graft-versus-host disease.
Li D, Cho MS, Gonzalez-Delgado R, Liang X, Dong JF, Cruz MA, Ma Q, Afshar-Kharghan V. Li D, et al. J Cell Mol Med. 2024 Jul;28(13):e18457. doi: 10.1111/jcmm.18457. J Cell Mol Med. 2024. PMID: 38963011 Free PMC article. - Calcineurin inhibitors suppress acute graft-versus-host disease via NFAT-independent inhibition of T cell receptor signaling.
Otsuka S, Melis N, Gaida MM, Dutta D, Weigert R, Ashwell JD. Otsuka S, et al. J Clin Invest. 2021 Jun 1;131(11):e147683. doi: 10.1172/JCI147683. J Clin Invest. 2021. PMID: 33822776 Free PMC article. - LFA-1 Mediates Cytotoxicity and Tissue Migration of Specific CD8+ T Cells after Heterologous Prime-Boost Vaccination against Trypanosoma cruzi Infection.
Ferreira CP, Cariste LM, Santos Virgílio FD, Moraschi BF, Monteiro CB, Vieira Machado AM, Gazzinelli RT, Bruna-Romero O, Menin Ruiz PL, Ribeiro DA, Lannes-Vieira J, Lopes MF, Rodrigues MM, de Vasconcelos JRC. Ferreira CP, et al. Front Immunol. 2017 Oct 13;8:1291. doi: 10.3389/fimmu.2017.01291. eCollection 2017. Front Immunol. 2017. PMID: 29081775 Free PMC article. - Advances in targeting co-inhibitory and co-stimulatory pathways in transplantation settings: the Yin to the Yang of cancer immunotherapy.
Kean LS, Turka LA, Blazar BR. Kean LS, et al. Immunol Rev. 2017 Mar;276(1):192-212. doi: 10.1111/imr.12523. Immunol Rev. 2017. PMID: 28258702 Free PMC article. Review. - Gas6 deficiency in recipient mice of allogeneic transplantation alleviates hepatic graft-versus-host disease.
Burnier L, Saller F, Kadi L, Brisset AC, Sugamele R, Baudino L, Bono F, Herbert JM, Carmeliet P, Schapira M, Izui S, Angelillo-Scherrer A. Burnier L, et al. Blood. 2010 Apr 22;115(16):3390-7. doi: 10.1182/blood-2009-02-206920. Epub 2010 Feb 4. Blood. 2010. PMID: 20139094 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources